Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Recruiting 2Unknown 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Head & Neck 3

Conditions

Neoplasms 43Breast Neoplasms 31Prostatic Neoplasms 27Colorectal Neoplasms 26Lung Neoplasms 17Hematopoietic and Lymphatic System Neoplasm 12Ovarian Neoplasms 11Hematologic Neoplasms 11Uterine Cervical Neoplasms 7Multiple Myeloma 7Lymphoma 7Leukemia 7Head and Neck Neoplasms 6Endometrial Neoplasms 6Depression 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Pancreatic Neoplasms 5Leukemia, Myeloid, Acute 5Urinary Bladder Neoplasms 4Rectal Neoplasms 4Mouth Neoplasms 4Motor Activity 4Melanoma 4Hematopoietic and Lymphoid System Neoplasm 4Gastrointestinal Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Anxiety Disorders 4Advanced Cancer 4Triple Negative Breast Neoplasms 3Stomach Neoplasms 3

Interventions

Cisplatin 43Radiotherapy 27Radiotherapy, Intensity-Modulated 24Radiation 16Carboplatin 14Surveys and Questionnaires 13Magnetic Resonance Spectroscopy 13Cetuximab 11Surgical Procedures, Operative 10pembrolizumab 9Specimen Handling 8Chemoradiotherapy 8Drug Therapy 7Docetaxel 7Biopsy 71,2-diaminocyclohexaneplatinum II citrate 7Platinum 6Paclitaxel 6Fluorouracil 6durvalumab 5X-Rays 5Observation 5Blood Specimen Collection 5Standard of Care 4Nivolumab 4Immunohistochemistry 4Celecoxib 4Taxes 3Neck Dissection 3Liquid Biopsy 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Oropharyngeal Neoplasms × Interviews as Topic × Clear all
NCT06997068 2026-05-11

Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States Population

Mayo Clinic

Phase 2 Recruiting
25 enrolled
Head & Neck

Carcinoma, Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

NCT06662058 2026-04-23

Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation

Emory University

Phase NA Recruiting
118 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Carcinoma, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

NCT00761397 2020-01-13

Adherence to Swallowing Exercises in Head and Neck Cancer

M.D. Anderson Cancer Center

Unknown
485 enrolled
Head & Neck

Head and Neck Neoplasms, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡